Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/2553
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDiyorakhon M. Mamajonova, Farkhad I. Shukurov,-
dc.date.accessioned2022-10-07T10:10:52Z-
dc.date.available2022-10-07T10:10:52Z-
dc.date.issued2022-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/2553-
dc.description.abstractAbstract Purpose: to study the features of the hormonal status and markers of the fetoplacental system in pregnant women after vaccination against COVID-19. Materials and research methods. The study included 120 pregnant women vaccinated with the Gam-Kovid-Vak vaccine against COVID-19. Of these, 60 women were vaccinated in the second trimester of pregnancy (main group I) and 60 in the third trimester of pregnancy (main group II), and the comparison group consisted of 30 pregnant women who refused vaccination. The study used clinical, hormonal, ultrasound, Doppler and statistical research methodsen_US
dc.language.isoen_USen_US
dc.publisherAmericaen_US
dc.subjectCoronavirus infection, Pregnancy, Vaccine, Hormones, Fetoplacental markersen_US
dc.titleFeatures State of the Fetoplacental System in Pregnant Women Vaccinated Against COVID-19en_US
dc.typeArticleen_US
Appears in Collections:Patents and Intellectual Property

Files in This Item:
File Description SizeFormat 
Diyorakhon M. Mamajonova. Америкада чоп этилган макола.pdfFeatures State of the Fetoplacental System in Pregnant Women Vaccinated Against COVID-19192.08 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.